February 2026's Undervalued Small Caps With Insider Actions To Consider

As February 2026 begins, U.S. stock markets have shown resilience with major indices like the Dow Jones and S&P 500 ending sharply higher, buoyed by positive economic indicators such as an unexpected expansion in factory activity. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking value and growth potential, especially when insider actions suggest confidence in a company's prospects amidst broader market optimism.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name PE PS Discount to Fair Value Value Rating CF Bankshares 11.9x 3.8x 34.83% ★★★★★☆ First United 9.6x 2.9x 47.44% ★★★★★☆ Bank of the James Financial Group 10.5x 1.9x 47.77% ★★★★☆☆ First Northern Community Bancorp 11.0x 3.2x 40.93% ★★★★☆☆ New Peoples Bankshares 9.8x 2.3x 39.07% ★★★☆☆☆ Community Bancorp 10.6x 3.8x 36.25% ★★★☆☆☆ Union Bankshares 10.0x 2.1x 19.76% ★★★☆☆☆ Farmland Partners 7.6x 9.4x -51.38% ★★★☆☆☆ Granite Ridge Resources 17.9x 1.6x 22.64% ★★★☆☆☆ FutureFuel NA 1.3x 41.28% ★★★☆☆☆

Click here to see the full list of 56 stocks from our Undervalued US Small Caps With Insider Buying screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Maravai LifeSciences Holdings

Simply Wall St Value Rating: ★★★★☆☆

Overview: Maravai LifeSciences Holdings specializes in providing nucleic acid production and biologics safety testing services, with a market cap of approximately $1.22 billion.

Operations: The company generates revenue primarily from Nucleic Acid Production and Biologics Safety Testing. Over recent periods, the gross profit margin has shown a notable decline, reaching 21.07% in the latest available data point. Operating expenses have consistently been significant, with General & Administrative Expenses being a major component of these costs.

PE: -3.6x

Maravai LifeSciences, a small U.S. company, shows insider confidence with Bernd Brust purchasing 250,559 shares for US$809,010 in recent transactions. Despite relying entirely on external borrowing for funding—considered higher risk—their strategic positioning in the life sciences sector offers potential growth opportunities. The company's focus on innovative solutions could enhance its market presence and attract investor interest as they navigate financial challenges and capitalize on industry trends.

Take a closer look at Maravai LifeSciences Holdings' potential here in our valuation report. Gain insights into Maravai LifeSciences Holdings' past trends and performance with our Past report.MRVI Share price vs Value as at Feb 2026

Dine Brands Global

Simply Wall St Value Rating: ★★★★★☆

Overview: Dine Brands Global operates a portfolio of restaurant brands, including IHOP and Applebee's, with diverse revenue streams from franchise operations, company restaurants, and rental activities; the company's market capitalization is approximately $1.24 billion.

Story Continues

Operations: Dine Brands Global generates revenue through various streams including franchise operations, rental, and company-owned restaurants. A significant portion of its revenue is derived from franchise operations, with advertising contributing notably as well. The company's gross profit margin has shown fluctuations over time, reaching 47.58% in the latest period. Operating expenses include general and administrative costs as a substantial component affecting net income margins.

PE: 14.8x

Dine Brands Global, a player in the restaurant industry, shows signs of being undervalued despite some financial challenges. The company faces high-risk funding due to reliance on external borrowing and has seen profit margins drop from 11.1% to 3.8%. However, insider confidence is evident as John Peyton recently purchased 4,523 shares for approximately US$100K. Additionally, the board's expansion with experienced members like Enrique Silva and Amanda Clark could signal strategic growth opportunities ahead.

Navigate through the intricacies of Dine Brands Global with our comprehensive valuation report here. Review our historical performance report to gain insights into Dine Brands Global's's past performance.DIN Share price vs Value as at Feb 2026

Farmland Partners

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Farmland Partners is a real estate investment trust (REIT) that focuses on owning and managing high-quality farmland across the United States, with a market capitalization of approximately $0.53 billion.

Operations: The company generates revenue primarily through its commercial real estate investment trust (REIT) activities, with a recent quarterly revenue of $52.99 million. Its cost structure includes cost of goods sold (COGS), operating expenses, and non-operating expenses, with COGS at $11.27 million in the latest period. The net income margin has shown significant variation over time, reaching 1.2369% recently due to changes in non-operating expenses and other financial factors impacting profitability.

PE: 7.6x

Farmland Partners, a small U.S. company, recently reported earnings for 2025 with sales at US$35.93 million and revenue of US$52.18 million, both down from the previous year. Net income also declined to US$31.55 million from US$59.91 million, reflecting challenges in their financial performance. Despite this, insider confidence is evident with recent share purchases by key figures within the company during the past year, suggesting potential belief in its future prospects despite expected earnings declines over the next three years due to large one-off items impacting results and reliance on external borrowing for funding.

Click here to discover the nuances of Farmland Partners with our detailed analytical valuation report. Understand Farmland Partners' track record by examining our Past report.FPI Ownership Breakdown as at Feb 2026

Seize The Opportunity

Explore the 56 names from our Undervalued US Small Caps With Insider Buying screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Interested In Other Possibilities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include MRVIDIN and FPI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments